Found: 4
Select item for more details and to access through your institution.
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22362-2
- By:
- Publication type:
- Article
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29413-2
- By:
- Publication type:
- Article
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29413-2
- By:
- Publication type:
- Article